Clinical trial
Comparison Between Pioglitazone and SES With type2 DM
NCT00482183 · Showa University, Other · Completed
Key facts
| NCT number | NCT00482183 |
|---|---|
| Title | Comparison Between Pioglitazone and SES With type2 DM |
| Official title | Comparison of Bare Metal Stent With Pioglitazone Versus Sirolimus-Eluting Stent for Percutaneous Coronary Intervention in Patients With Type 2 Diabetes Mellitus. |
| Lead sponsor | Showa University, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease, Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Pioglitazone |
| Enrollment | 38 |
| Start date | Jul 1, 2003 |
| Completion | Jun 1, 2007 |
| First posted | Jun 5, 2007 |
| Last update posted | Jun 5, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: